Company intelligence / Profile preview

Modus Health

United States

Ownership: Private
Development stage: Other

Overview

Modus Health’s StepWatch® Activity Monitor is CE marked, validated in over 600 peer-reviewed studies, and deployed in 71 countries and 145 clinical sites for accurate measurement of physical activity, especially in slow/irregular gait populations. It is widely regarded as the gold standard for objective mobility monitoring in research, clinical trials, and care settings[6].

Therapeutic areas: OtherNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Google (research product validation)Fitbit (monitor validation)Samsung Digital Health (monitor validation)[6]

Beyond the preview

Go deeper on Modus Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modus Health.

Explore the full profile